Royal Bank of Canada Reaffirms “Outperform” Rating for agilon health (NYSE:AGL)

agilon health (NYSE:AGL)‘s stock had its “outperform” rating reaffirmed by equities researchers at Royal Bank of Canada in a research note issued to investors on Tuesday,Benzinga reports. They presently have a $3.00 price objective on the stock. Royal Bank of Canada’s price target points to a potential upside of 88.09% from the stock’s previous close.

AGL has been the topic of a number of other research reports. Stifel Nicolaus cut their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Citigroup reduced their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a research report on Wednesday, November 13th. Benchmark reiterated a “buy” rating and issued a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. Finally, William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Three research analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, agilon health has a consensus rating of “Hold” and an average price target of $6.05.

agilon health Price Performance

Shares of agilon health stock traded up $0.03 during trading on Tuesday, reaching $1.60. 801,886 shares of the company’s stock were exchanged, compared to its average volume of 4,944,911. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 1-year low of $1.50 and a 1-year high of $13.76. The company has a market cap of $657.17 million, a P/E ratio of -1.71 and a beta of 0.60. The firm’s 50-day moving average price is $3.01 and its 200 day moving average price is $4.83.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period in the previous year, the firm posted ($0.06) EPS. As a group, research analysts anticipate that agilon health will post -0.47 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO Steven Sell acquired 20,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. The trade was a 42.03 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On agilon health

A number of large investors have recently bought and sold shares of the stock. J.Safra Asset Management Corp raised its holdings in shares of agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in agilon health in the 3rd quarter valued at about $28,000. City State Bank acquired a new position in agilon health during the 3rd quarter worth approximately $52,000. CWM LLC boosted its holdings in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after acquiring an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC acquired a new stake in agilon health in the second quarter valued at approximately $60,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.